Der tragbare Kardioverter/Defibrillator (WCD) – Indikationen und Einsatz
Authors:
- 4 July 2019
- journal article
- research article
- Published by Springer Nature in Der Kardiologe
- Vol. 13 (5) , 292-304
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Protection from Outpatient Sudden Cardiac Death following ICD Removal Using a Wearable Cardioverter DefibrillatorPacing and Clinical Electrophysiology, 2013
- Prognostic Value of Contrast-enhanced Cardiac Magnetic Resonance Imaging in Patients with Newly Diagnosed Non-Ischemic Cardiomyopathy: Cohort StudyPLOS ONE, 2013
- Wearable defibrillator use in heart failure (WIF): results of a prospective registryBMC Cardiovascular Disorders, 2012
- Long-Term Follow-Up of Biopsy-Proven Viral MyocarditisJACC, 2012
- The Extent of Left Ventricular Scar Quantified by Late Gadolinium Enhancement MRI Is Associated With Spontaneous Ventricular Arrhythmias in Patients With Coronary Artery Disease and Implantable Cardioverter-DefibrillatorsCirculation: Arrhythmia and Electrophysiology, 2011
- Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD)Pacing and Clinical Electrophysiology, 2010
- Update on Cardiovascular Implantable Electronic Device Infections and Their ManagementCirculation, 2010
- Defibrillator Implantation Early after Myocardial InfarctionNew England Journal of Medicine, 2009
- Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or BothNew England Journal of Medicine, 2005
- Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:Pacing and Clinical Electrophysiology, 2004